BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 303493)

  • 41. [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus].
    Blum C; Zillikens D; Tony HP; Hartmann AA; Burg G
    Hautarzt; 1993 May; 44(5):290-5. PubMed ID: 8320115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The application and value of immunofluorescence procedures in dermatology (author's transl)].
    Holubar K
    Wien Klin Wochenschr; 1974 Jun; 86(12):325-30. PubMed ID: 4599929
    [No Abstract]   [Full Text] [Related]  

  • 43. [Immunologic and immunogenetic heterogeneity of systemic and discoid lupus erythematosus].
    Konenkov VI; Korotkova IIu; Prokof'ev VF; Petrova EM; Lozovoĭ VP
    Ter Arkh; 1989; 61(5):31-4. PubMed ID: 2781486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune complexes in the pericardial fluid in systemic lupus erythematosus.
    Quismorio FP
    Arch Intern Med; 1980 Jan; 140(1):112-4. PubMed ID: 6965447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies of lymphocytotoxins in infectious mononucleosis and systemic lupus erythematosus: evidence for immune complex-mediated cytotoxicity.
    Quin JW; Charlesworth JA; Bowman C; Macdonald GJ
    Clin Exp Immunol; 1980 Mar; 39(3):593-8. PubMed ID: 6966548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polyethylene glycol precipitates of serum contain a large proportion of uncomplexed immunoglobulins and C3.
    Crowley-Nowick PA; Campbell E; Schrohenloher RE; Mestecky J; Mestecky J; Jackson S
    Immunol Invest; 1996; 25(1-2):91-101. PubMed ID: 8675237
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mannose binding lectin deposition in skin of lupus erythematosus patients: a case series.
    Wallim LR; Nisihara R; Skare T; Mocelin V; Messias-Reason IJ
    Hum Immunol; 2014 Jul; 75(7):629-32. PubMed ID: 24798938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic sclerosis (scleroderma) associated with discoid lupus erythematosus.
    Sasaki T; Nakajima H
    Dermatology; 1993; 187(3):178-81. PubMed ID: 8219419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lupus erythematosus panniculitis (profundus).
    Tuffanelli DL
    Arch Dermatol; 1971 Mar; 103(3):231-42. PubMed ID: 4100949
    [No Abstract]   [Full Text] [Related]  

  • 51. [Detection of circulating immune complexes (CIC) in systemic lupus erythematosus (SLE) by 125I-clq binding test (author's transl)].
    Yoshizawa N; Fujita K
    Nihon Jinzo Gakkai Shi; 1979 Oct; 21(10):1157-69. PubMed ID: 529614
    [No Abstract]   [Full Text] [Related]  

  • 52. Conglutinin binding polyethylene glycol precipitation assay for immune complexes.
    Macanovic M; Lachmann PJ
    Clin Exp Immunol; 1979 Nov; 38(2):274-83. PubMed ID: 118838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating immune complexes in nephritis.
    Coppo R; De Marchi M; Segoloni G; Quarello F; Piccoli G
    Ric Clin Lab; 1977; 7(4):354-64. PubMed ID: 353960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyroid autoantibodies in the subsets of lupus erythematosus: correlation with other autoantibodies and thyroid function.
    Konstadoulakis MM; Kroubouzos G; Tosca A; Piperingos G; Marafelia P; Konstadoulakis M; Varelzidis A; Koutras DA
    Thyroidology; 1993 Apr; 5(1):1-7. PubMed ID: 7508737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathways of complement activation in chronic discoid lupus: serologic and immunofluorescence studies.
    Schrager MA; Rothfield NF
    Arthritis Rheum; 1977 Mar; 20(2):637-45. PubMed ID: 322668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [C1q solid-phase radioimmunoassay for detection of circulating immune complexes in patients with systemic lupus erythematosus (author's transl)].
    Sato M; Kasukawa R; Suzuki S; Kameda S; Yoshida T
    Ryumachi; 1978 Mar; 18(2):97-103. PubMed ID: 307277
    [No Abstract]   [Full Text] [Related]  

  • 57. Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
    Kilpatrick JM; Virella G
    Diagn Immunol; 1983; 1(2):57-63. PubMed ID: 6388965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the incidence of discoid lupus erythematosus in patients with systemic lupus erythematosus and its relationship to disease activity.
    Saghafi M; Hashemzadeh K; Sedighi S; Yazdanpanah MJ; Rezaieyazdi Z; Sahebari M; Esmaily H
    J Cutan Med Surg; 2014 Oct; 18(5):316-9. PubMed ID: 25186992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Circulating immune complexes-like material and complement in rheumatoid arthritis and ankylosing spondylitis (author's transl)].
    Rodrigo MJ; Gallart MT; Lience E; Arnal C; Sans J
    Med Clin (Barc); 1981 Apr; 76(8):339-46. PubMed ID: 6789016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.
    Andres GA; Accinni L; Beiser SM; Christian CL; Cinotti GA; Erlanger BF; Hsu KC; Seegal BC
    J Clin Invest; 1970 Nov; 49(11):2106-18. PubMed ID: 4097660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.